Estimation of renal cell carcinoma treatment effects from disease progression modeling. [electronic resource]
Producer: 20130517Description: 345-51 p. digitalISSN:- 1532-6535
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Clinical Trials, Phase II as Topic -- statistics & numerical data
- Clinical Trials, Phase III as Topic -- statistics & numerical data
- Disease Progression
- Kidney Neoplasms -- drug therapy
- Models, Statistical
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Sorafenib
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.